Delivery Order SPE2DB20D1047-SPE2DB25FF53P

Award Date 4/10/25
Potential Completion Date 4/11/25
Potential Value $2.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $2,511.27, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Wegovy 1 mg/0.5 ml pens, a medication used for the treatment of chronic weight management. The contract is a Firm Fixed Price delivery order with an ultimate completion date of April 17, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...
This federal contract award, valued at $4,089.54, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Wegovy 0.5 mg/0.5 ml pens, a medication used for the treatment of obesity. The contract is a Firm Fixed Price Delivery Order that runs through February 28, 2025. It is not designated as a set-aside contract. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Wegovy 0.5 mg/0.5 ml pens. The $2,194.16 firm fixed-price delivery order has a completion date of June 27, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC covers a comprehensive...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Wegovy 2.4 mg/0.75 ml pens, a medication used in the treatment of obesity. The contract has a ceiling value of $3,842.83 and a completion date of December 19, 2023. It is a Firm Fixed Price Delivery Order contract with no set-aside designation, indicating open competition....
This is a federal contract award made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 0.25 mg/0.5 ml Wegovy pens, a medication for the treatment of obesity. The contract has a ceiling value of $5,588.37 and runs through March 4, 2025. It is a firm fixed-price delivery order contract, with no set-aside designation. AmerisourceBergen holds a larger $999,999,999 Indefinite...
This federal contract award, valued at $2,864.43, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Wegovy 2.4 mg/0.75 ml pens, a medication used for chronic weight management. The contract is a delivery order and has a firm fixed price pricing type. It is not designated as a set-aside contract. The ultimate completion date for this contract is February 28,...
This federal contract award is for the delivery of Wegovy 1.7 mg/0.75 ml pens in 0.75 ml quantities to the Defense Logistics Agency (DLA). The $1,714.73 Firm Fixed Price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on August 20, 2024 with a completion date of August 21, 2024. The contract is not designated with a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, the Corporate Office Division of Amerisourcebergen Corporation, a major pharmaceutical distribution company. The contract is for the delivery of Wegovy 2.4 mg/0.75 ml pens, a prescription medication for chronic weight management. The contract, valued at $2,610.40, is a Firm Fixed Price Delivery Order with a completion date of July 11, 2024. Amerisourcebergen holds a larger Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,901.00 firm fixed-price delivery order is for the supply of 0.5 mg/0.5 ml pens of the drug Wegovy, a medication used for weight management. The contract has an ultimate completion date of October 18, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distribution company. The $4,388.32 firm-fixed-price delivery order is for the supply of Wegovy 1.7 mg/0.75 ml pens, a medication used for weight management. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for a comprehensive range of medical...
  • SPE2DB20D1047
    Indefinite Delivery Contract
  • SPE2DB20D1047-SPE2DB25FF53P
    Delivery Order

This federal contract award, valued at $2,203.80, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The award is for the delivery of Wegovy 1 mg/0.5 ml pens, a medication used for the treatment of obesity. The contract is a firm-fixed-price delivery order with an ultimate completion date of April 11, 2025. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which serves as a comprehensive global pharmaceutical support vehicle through December 2026. This award is not designated as a set-aside contract, indicating open competition.

Generated 7/17/25, 6:28 PM